Skip to main content

Table 1 Distributions in measures of terminal duct lobular unit involution by breast cancer risk factors and tumor characteristics among Chinese patients with breast cancer

From: Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors

 

Overall (n = 504)

Measures of TDLU involution

Count/100 mm2

Maximum span (μm)

Maximum category of acini count/TDLUa

Subjects (n)

%

Median

(IQR)

Median

(IQR)

1–3

4–6

      

Number

%

Number

%

Age

 All, mean (SD)

50.4

9.4

        

 20–39 years

48

9.5

30.8

(15.7–48.0)

924

(759.5–1308.5)

14

5.0

34

15.3

 40–49 years

204

40.5

29.9

(17.4–44.6)

934.5

(712–1154)

71

25.2

133

59.9

 50–59 years

176

34.9

12.3

(7.0–22.9)

674

(532.5–847.5)

131

46.5

45

20.3

 60–79 years

76

15.1

8.7

(3.7–15.2)

559

(391.5–740)

66

23.4

10

4.5

P valueb

  

<0.0001

 

<0.0001

 

<0.0001

   

Body mass index

 All, mean (SD)

25.1

3.7

        

  < 23 kg/m2

155

30.9

19.2

(8.7–32.6)

773

(599–1075)

84

30.1

71

32.0

 23–24.9 kg/m2

121

24.2

19.0

(10.2–37.2)

747

(565–964)

67

24.0

54

24.3

 25–29.9 kg/m2

180

35.9

18.8

(9.1–36.8)

813.5

(613–1025)

98

35.1

82

36.9

 30+ kg/m2

45

9.0

14.3

(8.3–27.2)

784

(566–946)

30

10.8

15

6.8

P valueb

  

0.73

 

0.50

 

0.92

   

Family history of breast cancer

 No

470

95.0

18.3

(8.7–34.8)

775

(591–1023)

265

95.0

205

94.9

 Yes

25

5.1

17.1

(10.7–30.0)

751

(461–979)

14

5.0

11

5.1

P valueb

  

0.76

 

0.12

 

0.55

   

Age at menarche

  < 12 years

122

25.4

18.9

(10.8–38.6)

789.5

(603–1023)

68

24.7

54

26.2

 12–13 years

215

44.7

19.7

(8.5–36.3)

796

(611–1080)

112

40.7

103

50.0

 14+ years

144

29.9

15.4

(7.2–28.6)

713

(536.5–954)

95

34.6

49

23.8

P valueb

  

0.99

 

0.99

 

0.94

   

Parity/number of children

 Nulliparous

18

3.9

10.9

(4.6–36.6)

818

(482–1155)

11

4.2

7

3.4

 One child

290

62.1

20.0

(11.1–36.3)

804.5

(612–1075)

147

56.3

143

69.4

 More than one child

159

34.1

14.7

(7.3–33.8)

754

(547–955)

103

39.5

56

27.2

P valueb

  

0.02

 

0.14

 

0.06

   

Breastfeedingc

 No

19

6.2

15.4

(7.8–28.1)

565

(468–887)

14

8.1

5

3.8

 Yes

286

93.8

18.3

(9.0–34.2)

790.5

(621–1025)

158

91.9

128

96.2

P valueb

  

0.48

 

0.05

 

0.08

   

Tumor subtype

 Luminal A

254

50.4

17.4

(8.3–32.8)

764.5

(600–992)

152

53.9

102

46.0

 Triple-negative/core basal phenotype

250

49.6

19.5

(10.0–37.8)

803

(588–1043)

130

46.1

120

54.1

P valueb

  

0.45

 

0.10

 

0.03

   

Tumor size

  ≤ 2 cm

277

56.4

18.3

(8.3–34.2)

777

(583–998)

160

58.4

117

53.9

  > 2 cm

214

43.6

20.0

(10.1–35.8)

794

(606–1034)

114

41.6

100

46.1

P valueb

  

0.71

 

0.76

 

0.19

   

Lymph node invasion

 Negative

286

58.7

17.6

(9.4–34.9)

780.5

(566–989)

160

58.6

126

58.9

 Positive

201

41.3

19.8

(8.4–34.1)

781

(604–1075)

113

41.4

88

41.1

P valueb

  

0.86

 

0.27

 

0.81

   

Grade

 Well differentiated

47

10.2

20.3

(8.3–40.0)

887

(644–1198)

26

10.0

21

10.5

 Moderately differentiated

201

43.5

17.5

(9.4–36.0)

770

(599–979)

113

43.3

88

43.8

 Poorly differentiated

214

46.3

18.7

(9.2–33.0)

774.5

(566–1025)

122

46.7

92

45.8

P valueb

  

0.32

 

0.01

 

0.07

   
  1. TDLU Terminal duct lobular unit
  2. aCategories for acini count/TDLU: 1 = 2–10, 2 = 11–20, 3 = 21–30, 4 = 31–50, 5 = 51–100, and 6 = >100
  3. b P values were obtained from ordinal logistic regression models using tertiles of TDLU involution measures as the outcome variable and age (5-year intervals), body mass index (<23, 23–24.9, 25–29.9, or 30+ kg/m2), parity (nulliparous, one child, and more than one child), tumor subtype (luminal A and triple-negative/core basal phenotype), and grade (well, moderately, or poorly differentiated) as explanatory variables
  4. cParous women only